Citation: P. Caffes et C. Weiler, INHIBITION OF IL-5 ACTIVITY WITH A SYNTHETIC PEPTIDE, Journal of allergy and clinical immunology, 101(1), 1998, pp. 438-438
Authors:
WOLF B
DINGER V
WEILER C
SCHWINDE A
SCHEIPERS P
KRAUS M
Citation: B. Wolf et al., DRUG TARGETING AND METABOLIC INVESTIGATIONS OF CRYOPREPARED TUMOR-CELLS WITH ANALYTICAL ELECTRON-ENERGY-LOSS SPECTROSCOPY, Tumor biology, 17(4), 1996, pp. 234-250
Citation: C. Weiler, PUBLIC ENTREPRENEURS - AGENTS FOR CHANGE IN AMERICAN GOVERNMENT - SCHNEIDER,M, TESKE,P, The Journal of politics, 58(2), 1996, pp. 563-565
Authors:
VILLEMOES P
WANG M
ARNESEN A
WEILER C
WANNSTROM A
Citation: P. Villemoes et al., ISOTOPE SHIFTS AND HYPERFINE-STRUCTURE OF OPTICAL-TRANSITIONS IN (SMII)-SM-147-150,152,154 BY FAST-ION-BEAM-LASER SPECTROSCOPY, Physical review. A, 51(4), 1995, pp. 2838-2850
Citation: C. Weiler, A COMPARISON OF 2 AVALANCHE-MODELS WITH EXEMPLARY AVALANCHES OF TYROLAND SWITZERLAND AND THE EFFECTS TO HAZARD ZONING, Surveys in geophysics, 16(5-6), 1995, pp. 671-679
Citation: Mj. Murray et al., THE USE OF NEUROMUSCULAR BLOCKING-DRUGS IN THE INTENSIVE-CARE UNIT - A US PERSPECTIVE, Intensive care medicine, 19, 1993, pp. 190000040-190000044